Income Statement

Revenue

+29%

+86%

10Y

Currency: KRW

	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	12	12	8	4	3	0	0	26	98	176	280	360	400	401	363	331	288	348	385	374	368	309	269	280	286	204	207	198	227	192	147	127	126	119	125	105	100	98	75	0	26	0	0	4	0	0	38	92	151	208	263	0	89	95	13	138	269	646	924	1 058	1 182	1 073	1 171	1 594	2 078	2 617	3 133	3 555	3 683	3 984	4 258	4 306	4 614	5 975	7 142	8 655	9 306	0	0	0
Revenue	47 267 N/A	50 011 +6%	53 852 +8%	55 958 +4%	60 060 +7%	64 279 +7%	67 523 +5%	71 185 +5%	74 357 +4%	77 865 +5%	81 300 +4%	86 183 +6%	90 659 +5%	94 512 +4%	100 259 +6%	106 948 +7%	115 931 +8%	125 491 +8%	134 445 +7%	141 830 +5%	144 696 +2%	143 682 -1%	142 509 -1%	138 397 -3%	138 875 +0%	136 670 -2%	136 707 +0%	137 541 +1%	138 168 +0%	143 526 +4%	147 871 +3%	152 578 +3%	158 879 +4%	165 717 +4%	168 940 +2%	174 309 +3%	181 985 +4%	190 869 +5%	201 669 +6%	208 007 +3%	216 187 +4%	223 755 +4%	231 178 +3%	236 796 +2%	240 722 +2%	245 490 +2%	248 351 +1%	258 276 +4%	265 462 +3%	273 785 +3%	279 934 +2%	279 338 0%	286 653 +3%	291 785 +2%	299 872 +3%	310 803 +4%	317 828 +2%	322 124 +1%	318 090 -1%	318 296 +0%	308 501 -3%	302 889 -2%	315 869 +4%	330 686 +5%	354 176 +7%	396 239 +12%	425 588 +7%	457 308 +7%	478 885 +5%	485 917 +1%	501 899 +3%	508 634 +1%	526 952 +4%	561 164 +6%	566 094 +1%	593 945 +5%	598 162 +1%	597 693 0%	603 589 +1%	590 698 -2%
Gross Profit
Cost of Revenue	(15 891)	(16 727)	(18 315)	(18 655)	(20 345)	(21 234)	(21 863)	(23 322)	(24 178)	(25 266)	(26 642)	(28 134)	(30 846)	(33 375)	(36 515)	(39 724)	(44 438)	(48 186)	(51 606)	(56 277)	(57 155)	(57 350)	(58 581)	(58 465)	(61 651)	(61 955)	(64 679)	(65 886)	(65 622)	(68 440)	(69 826)	(70 814)	(73 865)	(77 538)	(77 537)	(78 747)	(81 683)	(85 698)	(91 895)	(95 621)	(99 036)	(103 071)	(105 011)	(105 064)	(103 208)	(104 936)	(104 027)	(107 985)	(113 418)	(114 203)	(116 966)	(117 482)	(121 164)	(124 759)	(130 081)	(136 222)	(137 672)	(140 662)	(141 082)	(144 048)	(142 564)	(143 038)	(150 801)	(162 036)	(177 709)	(200 482)	(216 709)	(231 166)	(240 943)	(244 797)	(253 236)	(260 811)	(269 705)	(284 080)	(291 135)	(303 814)	(310 832)	(316 631)	(322 513)	(323 696)
Gross Profit	31 376 N/A	33 284 +6%	35 538 +7%	37 304 +5%	39 715 +6%	43 045 +8%	45 658 +6%	47 861 +5%	50 179 +5%	52 598 +5%	54 659 +4%	58 050 +6%	59 813 +3%	61 138 +2%	63 744 +4%	67 225 +5%	71 493 +6%	77 306 +8%	82 841 +7%	85 554 +3%	87 541 +2%	86 332 -1%	83 927 -3%	79 931 -5%	77 223 -3%	74 716 -3%	72 029 -4%	71 656 -1%	72 546 +1%	75 086 +4%	78 046 +4%	81 765 +5%	85 014 +4%	88 180 +4%	91 403 +4%	95 562 +5%	100 302 +5%	105 171 +5%	109 773 +4%	112 385 +2%	117 151 +4%	120 683 +3%	126 167 +5%	131 731 +4%	137 514 +4%	140 553 +2%	144 322 +3%	150 290 +4%	152 044 +1%	159 581 +5%	162 968 +2%	161 856 -1%	165 488 +2%	167 025 +1%	169 790 +2%	174 580 +3%	180 155 +3%	181 462 +1%	177 008 -2%	174 248 -2%	165 937 -5%	159 850 -4%	165 068 +3%	168 649 +2%	176 468 +5%	195 757 +11%	208 879 +7%	226 142 +8%	237 942 +5%	241 120 +1%	248 663 +3%	247 824 0%	257 247 +4%	277 084 +8%	274 959 -1%	290 131 +6%	287 330 -1%	281 062 -2%	281 077 +0%	267 002 -5%
Operating Income
Operating Expenses	(24 300)	(26 318)	(27 240)	(28 213)	(30 576)	(32 008)	(34 842)	(37 298)	(40 630)	(42 961)	(44 938)	(48 433)	(48 252)	(50 162)	(52 057)	(52 555)	(57 432)	(60 309)	(62 989)	(64 382)	(65 547)	(64 483)	(63 950)	(63 191)	(63 842)	(64 852)	(63 507)	(62 800)	(59 048)	(63 150)	(64 543)	(66 111)	(69 469)	(72 842)	(76 791)	(78 995)	(82 496)	(84 891)	(87 833)	(91 308)	(94 066)	(96 379)	(101 086)	(102 475)	(108 367)	(113 450)	(116 665)	(122 283)	(126 750)	(131 537)	(134 868)	(134 044)	(134 743)	(137 201)	(139 112)	(142 631)	(145 049)	(144 847)	(141 430)	(142 019)	(141 838)	(148 816)	(156 965)	(159 088)	(157 042)	(161 251)	(167 549)	(177 971)	(194 936)	(205 209)	(210 732)	(217 732)	(225 015)	(238 852)	(248 142)	(258 676)	(259 110)	(258 414)	(258 482)	(266 157)
Selling, General & Administrative	(22 947)	(24 829)	(25 736)	(26 627)	(28 785)	(30 363)	(32 557)	(35 084)	(38 272)	(40 614)	(43 128)	(46 179)	(46 359)	(48 232)	(50 144)	(50 685)	(54 961)	(57 663)	(59 855)	(61 494)	(62 654)	(61 108)	(60 629)	(58 536)	(57 266)	(56 573)	(54 692)	(55 042)	(53 027)	(55 280)	(56 703)	(59 384)	(62 564)	(64 591)	(68 221)	(68 703)	(71 197)	(72 937)	(74 767)	(79 206)	(85 355)	(89 594)	(94 240)	(96 925)	(100 609)	(103 828)	(107 434)	(112 835)	(118 750)	(122 262)	(124 035)	(124 092)	(124 018)	(124 407)	(126 109)	(130 069)	(132 302)	(131 659)	(129 000)	(126 868)	(125 742)	(132 740)	(140 094)	(143 164)	(142 963)	(143 958)	(150 380)	(157 789)	(172 194)	(180 401)	(187 806)	(195 162)	(203 793)	(216 123)	(222 707)	(230 935)	(231 351)	(230 308)	(230 656)	(237 720)
Research & Development	(823)	(981)	(1 077)	(1 128)	(1 348)	(1 209)	(1 838)	(1 784)	(1 918)	(1 908)	(1 367)	(1 792)	(1 524)	(1 597)	(1 596)	(1 581)	(2 128)	(2 302)	(2 757)	(2 516)	(2 507)	(2 912)	(2 828)	(3 899)	(5 839)	(6 111)	(6 600)	(6 324)	(5 089)	(5 434)	(5 379)	(5 745)	(5 930)	(6 446)	(6 768)	(8 505)	(10 317)	(10 991)	(11 602)	(11 072)	(7 622)	(5 644)	(5 656)	(4 398)	(6 634)	(6 751)	(6 339)	(6 512)	(6 762)	(6 737)	(8 206)	(8 563)	(9 275)	(11 002)	(10 965)	(10 313)	(10 244)	(10 013)	(9 223)	(11 871)	(13 478)	(12 741)	(13 579)	(12 596)	(11 302)	(13 294)	(14 146)	(15 747)	(19 473)	(19 234)	(19 677)	(19 449)	(18 207)	(19 160)	(20 607)	(22 158)	(21 926)	(22 150)	(21 867)	(22 297)
Depreciation & Amortization	(531)	(506)	(426)	(458)	(443)	(438)	(449)	(431)	(440)	(438)	(442)	(460)	(370)	(332)	(316)	(289)	(344)	(344)	(408)	(404)	(453)	(531)	(530)	(793)	(737)	(787)	(859)	(745)	(931)	(949)	(975)	(983)	(976)	(996)	(994)	(992)	(981)	(966)	(958)	(1 031)	(1 089)	(1 141)	(1 191)	(1 153)	(1 124)	(1 118)	(1 133)	(1 183)	(1 238)	(1 241)	(1 331)	(1 389)	(1 449)	(1 784)	(2 029)	(2 247)	(2 502)	(2 517)	(2 549)	(2 623)	(2 618)	(2 619)	(2 577)	(2 612)	(2 777)	(2 888)	(3 023)	(3 195)	(3 268)	(3 421)	(3 249)	(3 121)	(3 015)	(3 569)	(4 827)	(5 583)	(5 832)	(5 955)	(5 960)	(6 140)
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	30	32	67	68	37	37	0	(1 381)	(1 356)	(689)	0	(1 487)	(1 486)	0	0	(809)	(808)	(795)	0	3	(506)	0	0	0	0	0	0	(1 753)	(1 759)	(1 753)	0	(1 297)	(1 296)	0	0	(8)	(9)	0	0	(658)	(658)	(657)	0	(716)	(715)	(716)	0	(1 111)	0	(1 240)	0	(2 154)	0	0	0	0	0	0	0	0	0	0
Operating Income	7 076 N/A	6 967 -2%	8 297 +19%	9 090 +10%	9 139 +1%	11 036 +21%	10 817 -2%	10 563 -2%	9 549 -10%	9 637 +1%	9 720 +1%	9 618 -1%	11 561 +20%	10 978 -5%	11 689 +6%	14 670 +26%	14 060 -4%	16 997 +21%	19 851 +17%	21 171 +7%	21 994 +4%	21 847 -1%	19 976 -9%	16 740 -16%	13 382 -20%	9 863 -26%	8 522 -14%	8 856 +4%	13 498 +52%	11 937 -12%	13 503 +13%	15 654 +16%	15 545 -1%	15 338 -1%	14 612 -5%	16 567 +13%	17 806 +7%	20 280 +14%	21 940 +8%	21 076 -4%	23 085 +10%	24 302 +5%	25 080 +3%	29 257 +17%	29 147 0%	27 106 -7%	27 660 +2%	28 009 +1%	25 295 -10%	28 045 +11%	28 100 +0%	27 812 -1%	30 745 +11%	29 825 -3%	30 678 +3%	31 949 +4%	35 107 +10%	36 615 +4%	35 579 -3%	32 230 -9%	24 099 -25%	11 034 -54%	8 104 -27%	9 562 +18%	19 426 +103%	34 506 +78%	41 329 +20%	48 171 +17%	43 006 -11%	35 911 -16%	37 931 +6%	30 092 -21%	32 233 +7%	38 232 +19%	26 817 -30%	31 455 +17%	28 220 -10%	22 648 -20%	22 594 0%	845 -96%
Pre-Tax Income
Interest Income Expense	(91)	(73)	317	324	437	515	570	798	824	776	772	562	(966)	(62)	(248)	(1 523)	(538)	(1 069)	(1 086)	58	1 308	861	904	1 057	(552)	142	287	138	334	573	603	803	731	534	496	498	962	969	944	906	505	344	318	220	439	363	543	568	150	305	118	181	124	469	525	211	984	609	280	152	1 515	2 080	1 997	2 039	(1 962)	(2 756)	(2 829)	(2 941)	(2 222)	(2 636)	(2 883)	(3 153)	(2 629)	(3 434)	(4 435)	(5 972)	(7 868)	(7 392)	(8 380)	(6 688)
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	287	268	(158)	6	(300)	(307)	66	0	0	0	(616)	(1 485)	0	0	(1 499)	(830)	0	0	0	(457)	(507)	0	(539)	(276)	(231)	(226)	(200)	(1 758)	0	0	0	(1 296)	0	0	(1 303)	(7)	0	0	0	(656)	0	0	0	(716)	0	0	0	(1 111)	0	(1 240)	0	(2 154)	0	(2 306)	(2 548)	(4 597)	(6 556)	(6 243)	(6 000)	(2 501)	(840)	(991)	(1 020)
Gain/Loss on Disposition of Assets	(491)	0	(451)	(275)	(300)	(295)	(428)	(376)	(381)	(394)	(388)	(439)	(517)	(510)	(533)	(516)	(577)	0	0	0	0	0	0	0	(115)	0	0	0	(11)	(4)	(183)	0	(172)	(164)	15	25	25	10	(2)	(26)	(65)	234	246	259	318	23	0	33	(46)	(32)	(183)	0	(141)	(158)	(7)	32	(2)	0	(8)	(39)	2	0	7	(1)	(1)	3	94	61	46	43	110	143	150	207	(35)	37	(20)	(281)	(196)	(190)
Total Other Income	(274)	(729)	(636)	(634)	(1 505)	(1 448)	(977)	(994)	(318)	(309)	(312)	(774)	(299)	(293)	(189)	104	(595)	(1 100)	(1 654)	(1 343)	(1 595)	(1 993)	(1 279)	(1 604)	(186)	(13)	(136)	182	218	323	458	650	329	461	504	1 366	2 789	2 766	2 727	1 779	(2)	(1 566)	(1 910)	(2 303)	(395)	(583)	(489)	(556)	(578)	(523)	(501)	(713)	489	192	91	535	(61)	(69)	(1 168)	(1 227)	(1 259)	(960)	239	328	784	496	429	103	45	183	588	589	673	839	573	(366)	(1 673)	(3 513)	(2 686)	(2 915)
Pre-Tax Income	6 219 N/A	6 165 -1%	7 527 +22%	8 505 +13%	7 771 -9%	9 809 +26%	9 982 +2%	9 992 +0%	9 674 -3%	9 710 +0%	9 793 +1%	8 968 -8%	9 779 +9%	10 113 +3%	10 719 +6%	12 734 +19%	12 350 -3%	15 115 +22%	17 379 +15%	19 728 +14%	21 713 +10%	20 415 -6%	19 293 -5%	16 257 -16%	12 529 -23%	9 991 -20%	8 673 -13%	8 561 -1%	12 555 +47%	12 831 +2%	14 383 +12%	15 608 +9%	15 602 0%	16 169 +4%	15 626 -3%	18 454 +18%	21 124 +14%	23 516 +11%	25 609 +9%	23 197 -9%	23 247 +0%	23 084 -1%	23 508 +2%	27 234 +16%	27 751 +2%	26 908 -3%	27 714 +3%	28 052 +1%	23 525 -16%	27 796 +18%	27 535 -1%	25 977 -6%	31 210 +20%	30 328 -3%	31 288 +3%	32 727 +5%	35 372 +8%	37 157 +5%	34 683 -7%	31 117 -10%	23 642 -24%	12 154 -49%	10 348 -15%	11 928 +15%	17 136 +44%	32 249 +88%	37 783 +17%	45 394 +20%	38 722 -15%	33 501 -13%	33 440 0%	25 123 -25%	25 830 +3%	29 288 +13%	16 676 -43%	19 155 +15%	16 159 -16%	10 622 -34%	10 341 -3%	(9 968) N/A
Net Income
Tax Provision	(1 421)	(1 470)	(1 471)	(1 849)	(2 146)	(2 818)	(3 350)	(2 904)	(1 854)	(1 810)	(1 528)	(1 668)	(2 105)	(2 402)	(2 624)	(3 317)	(2 588)	(2 832)	(3 580)	(4 067)	(8 683)	(8 712)	(8 691)	(7 953)	(3 272)	(2 301)	(1 667)	(1 433)	(2 789)	(2 871)	(3 124)	(3 498)	(3 369)	(3 644)	(3 780)	(4 386)	(5 527)	(6 382)	(6 251)	(6 069)	(5 913)	(5 722)	(7 182)	(6 925)	(8 028)	(7 806)	(15 073)	(13 799)	(13 250)	(14 042)	(6 226)	(8 300)	(7 924)	(7 996)	(7 973)	(8 079)	(8 493)	(8 691)	(8 077)	(7 494)	(6 443)	(10 378)	(10 049)	(8 833)	(10 525)	(7 353)	(8 729)	(11 811)	(8 065)	(3 491)	(2 527)	430	(2 367)	(6 363)	(4 024)	(6 192)	(6 055)	(4 590)	(5 368)	(8 730)
Income from Continuing Operations	4 798	4 695	6 056	6 656	5 624	6 991	6 632	7 088	7 819	7 899	8 263	7 297	7 673	7 710	8 096	9 419	9 762	12 285	13 800	15 661	13 030	11 704	10 603	8 306	9 257	7 691	7 007	7 129	9 766	9 961	11 260	12 112	12 233	12 526	11 847	14 068	15 597	17 134	19 358	17 128	17 333	17 362	16 325	20 308	19 723	19 101	12 641	14 253	10 275	13 753	21 308	17 675	23 286	22 331	23 314	24 649	26 879	28 467	26 607	23 623	17 198	1 775	299	3 096	6 611	24 895	29 054	33 583	30 657	30 010	30 913	25 552	23 463	22 925	12 652	12 963	10 104	6 032	4 973	(18 698)
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	179	(137)	(173)	(157)	(151)	(26)	22	99	88	99	130	76	131	153	238	325	361	429	386	479	519	530	540	410	467	460	471	519	458	464	460	437	410	438	429	449	442	344	359	335	378	680	874	1 145	1 287	1 061	836	581	454	608	2 036	3 056	5 165	5 429	4 443	3 893
Net Income (Common)	4 798 N/A	4 695 -2%	6 056 +29%	6 656 +10%	5 624 -16%	6 991 +24%	6 632 -5%	7 088 +7%	7 819 +10%	7 899 +1%	8 263 +5%	7 297 -12%	7 673 +5%	7 710 +0%	8 096 +5%	9 419 +16%	9 762 +4%	12 285 +26%	13 800 +12%	15 661 +13%	13 030 -17%	11 704 -10%	10 603 -9%	8 306 -22%	9 436 +14%	7 733 -18%	7 014 -9%	7 152 +2%	9 615 +34%	9 935 +3%	11 280 +14%	12 209 +8%	12 321 +1%	12 625 +2%	11 977 -5%	14 144 +18%	15 729 +11%	17 287 +10%	19 597 +13%	17 454 -11%	17 695 +1%	17 791 +1%	16 763 -6%	20 788 +24%	20 242 -3%	19 632 -3%	13 129 -33%	14 662 +12%	10 742 -27%	14 213 +32%	21 780 +53%	18 195 -16%	23 744 +30%	22 795 -4%	23 773 +4%	25 085 +6%	27 289 +9%	28 904 +6%	27 037 -6%	24 073 -11%	17 640 -27%	2 120 -88%	658 -69%	3 431 +422%	6 989 +104%	25 575 +266%	29 928 +17%	34 728 +16%	31 944 -8%	31 071 -3%	31 749 +2%	26 133 -18%	23 917 -8%	23 534 -2%	14 688 -38%	16 019 +9%	14 210 -11%	10 383 -27%	8 164 -21%	(16 037) N/A
EPS (Diluted)	252.52 N/A	247.1 -2%	318.73 +29%	350.31 +10%	296 -16%	349.55 +18%	331.6 -5%	354.4 +7%	390.95 +10%	394.95 +1%	434.89 +10%	384.05 -12%	403.84 +5%	405.78 +0%	426.1 +5%	495.73 +16%	513.78 +4%	614.25 +20%	690 +12%	783.05 +13%	651.5 -17%	532 -18%	481.95 -9%	377.54 -22%	428.9 +14%	429.61 +0%	318.81 -26%	325.09 +2%	437.04 +34%	451.59 +3%	512.72 +14%	554.95 +8%	560.04 +1%	601.19 +7%	544.4 -9%	642.9 +18%	714.95 +11%	785.77 +10%	890.77 +13%	793.36 -11%	804.31 +1%	808.68 +1%	761.95 -6%	944.9 +24%	963.9 +2%	934.85 -3%	625.19 -33%	698.19 +12%	511.52 -27%	676.8 +32%	1 037.14 +53%	866.42 -16%	1 130.66 +30%	1 085.47 -4%	1 132.04 +4%	1 194.52 +6%	1 299.47 +9%	1 376.38 +6%	1 287.47 -6%	1 146.33 -11%	840 -27%	99.91 -88%	31 -69%	161.7 +422%	329.36 +104%	1 205.3 +266%	1 410.95 +17%	1 583.91 +12%	1 510 -5%	1 451.61 -4%	1 513.99 +4%	1 206.48 -20%	1 139.91 -6%	1 109.41 -3%	692.96 -38%	747.38 +8%	667.42 -11%	479.32 -28%	380.92 -21%	-748.2 N/A

Income Statement Balance Sheet Cash Flow Statement

Daewon Pharmaceutical Co Ltd
KRX:003220

Income Statement

Earnings Waterfall
Daewon Pharmaceutical Co Ltd

Income Statement
Daewon Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Daewon Pharmaceutical Co Ltd KRX:003220

Income Statement

Earnings Waterfall Daewon Pharmaceutical Co Ltd

Income Statement Daewon Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Daewon Pharmaceutical Co Ltd
KRX:003220

Earnings Waterfall
Daewon Pharmaceutical Co Ltd

Income Statement
Daewon Pharmaceutical Co Ltd